| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Surgical and Oncological Sciences (M.T., G.S.), School of Medicine, and Department of Medical Biotechnologies and Legal Medicine (F.D.G.), Section of Clinical Biochemistry, University of Palermo, 90127 Palermo, Italy; Dipartimento di Medicina Sperimentale (M.L.), Ambientale e Biotecnologie Mediche, Università Milano-Bicocca, 20125 Milano, Italy; and Department of Experimental Medicine (G.P.), Laboratory of Histology and Embryology, School of Medicine, 2nd University of Naples, 80138 Naples, Italy
Address all correspondence and requests for reprints to: Gianpaolo Papaccio, M.D., Ph.D., Department of Experimental Medicine, Laboratory of Histology, School of Medicine, 2nd University of Naples, 5 via L. Armanni, 80138 Naples, Italy. E-mail: gianpaolo.papaccio{at}unina2.it.
IL-1ß is recognized as an effector cytokine contributing to islet ß-cell destruction during diabetes. We have previously shown in vitro that IL-1ß induces nitric oxide (NO) and ß-cell damage. Here, we show that IL-1ß administration in vivo to Wistar rats transiently increases manganese superoxide dismutase activity, whereas inducible NO synthase is not detected, and the levels of nitrate+nitrate do not change. Moreover, a significant decrease of mitochondrial aconitase, leading to a rise of hydroperoxides, and islet ß-cell apoptosis, involving caspase-3 and -8, is observed. Analysis of adhesion molecules in ß-cells showed that intercellular adhesion molecule-1 is highly expressed 48 h after IL-1ß administration and that this is concomitant to the fall of manganese superoxide dismutase activity. Thus, IL-1ß exerts a proapoptotic effect in vivo through mitochondrial enzyme alteration, which is not related to the inducible NO synthase pathway, and dysregulates the immune system through the up-regulation of adhesion molecules.
This article has been cited by other articles:
![]() |
K. L A Souza, E. Gurgul-Convey, M. Elsner, and S. Lenzen Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells J. Endocrinol., April 1, 2008; 197(1): 139 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Mathews, W. L. Suarez-Pinzon, J. J. Baust, K. Strynadka, E. H. Leiter, and A. Rabinovitch Mechanisms Underlying Resistance of Pancreatic Islets from ALR/Lt Mice to Cytokine-Induced Destruction J. Immunol., July 15, 2005; 175(2): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hammar, G. Parnaud, D. Bosco, N. Perriraz, K. Maedler, M. Donath, D. G. Rouiller, and P. A. Halban Extracellular Matrix Protects Pancreatic {beta}-Cells Against Apoptosis: Role of Short- and Long-Term Signaling Pathways Diabetes, August 1, 2004; 53(8): 2034 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Lowe Jr. "The Matrix Unloaded": Implications for Cytokine Signaling in Islets? Endocrinology, October 1, 2003; 144(10): 4262 - 4263. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |